Growth

AGE                  

In utero                

Birth                    

Infancy                

Childhood           

Adolescence      

Adult              

Growth Deficit

Small for gestational age

Small at birth

3rd – 10th percentile

3rd percentile, slow growth

Below 3rd percentile, no growth spurt

Adult height 20 cm below population

Girl
Children's Growth Chart Calculator

There is treatment to augment the primary characteristic clinical short stature in young females with Turner Syndrome. But, time is of the essence to initiate treatment, as growth will be inhibited after a certain age and development.

Short stature is the single most common physical abnormality in Turner Syndrome, and individuals not treated with growth-promoting techniques achieve an adult stature 20 cm shorter than that of the normal population to a final height on average 4’7″. The American Association of Clinical Endocrinologists defines short stature as height more than 2 standard deviations below the mean for age and gender, which corresponds to the shortest 2.3% of individuals. Short stature is the only clinical finding invariably associated with the 45,X karyotype; it also is the only phenotypic abnormality present in majority of patients.

The height of patients with Turner Syndrome, when plotted on growth curves specific for this disorder, show that growth velocity declines often as early as two to four years of age and referral for screening occurs five to seven years after the evidence of growth failure. Final height is compromised by a delay in the onset of treatment.

Identifying Issues

Most symptoms of Turner Syndrome occur because of the loss of genetic material from one of the X chromosomes. To date, only one gene has been shown to play a role in the development of Turner Syndrome. The Short Stature Homeobox Gene (SHOX) gene plays a role in the growth and development of the skeleton. Scientists believe the loss of one SHOX gene is the main cause of short stature in Turner Syndrome.

Patients with Turner Syndrome generally do not have growth hormone deficiency (GHD). Girls with Turner Syndrome make growth hormone naturally in the pituitary gland, but their bodies do not use it appropriately. However, by taking additional growth hormone that is synthetically made, there is a dramatic increase in growth. Treatment for short stature will also affect other aspects of this disorder, including the age to initiate estrogen replacement therapy, socialization, and academic achievement.

Bone X-ray 

A hand and wrist x-ray will provide a view into growth potential as compared to children the same age, and in older children to see if their growth plates have closed. A child’s growth rate (velocity) is more important than actual height. An average child will grow 2 – 2.5 inches per year.

Treatment for short stature in girls with Turner Syndrome will affect many other aspects of this disorder, including the age to initiate estrogen replacement therapy, socialization, and academic achievement.

Resources

To read more about GROWTH, scroll to page(s) G15-G17 in the Clinical Guidelines found here: https://turnersyndromefoundation.org/wp-content/uploads/2017/07/Clinical-Practice-Guideslines-International-G1-2017.full_.pdf

©2023 Copyright Turner Syndrome Foundation - All rights Reserved.

X
%d bloggers like this: